At a glance
- Originator Pharmacia Corporation
- Class Antiplatelets
- Mechanism of Action Phospholipase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 04 Feb 1998 Discontinued-Preclinical for Thrombosis in USA (Unknown route)